Synthesis and Biological Evaluation of Potent Antihypertensive Activity: 2-[(Substituted-phenyl amino)-phenyl-methyl]-1-[2'-(1H-tetrazol-5-yl) biphenyl-3-ylmethyl]-1H-benzoimidazol-5-ylamine Derivatives
Keywords:
Benzimidazoles, Biphenyl tetrazole, Angiotension-II, antihypertensive agentsAbstract
Some new 2-[(Substituted-phenyl amino)-phenyl-methyl]-1-[2'-(1Htetrazol-5-yl) biphenyl-3-ylmethyl]-1H-benzoimidazol-5-ylamine Derivatives were synthesised by 2-( α -hydroxy benzyl) benzimidazole was converted to 2-(α-bromo benzyl) benzimidazole by reacting with Con.Nitric acid, sulphuric acid HBr and Anhydrous ZnCl2 Schiff bases react with ortho position attach biphenyl tetrazole with different substituents amino group cyclocondensation with appropriate reagents. Different from the previously reported and related compounds in that they produce a potent hypertensive effect the compounds synthesised were identified by 1H NMR, 13C NMR, FAB Mass and FT-IR spectroscopic techniques. All compounds studied in this work were screened for their antihypertensive activity by tail cuff method and direct method measurement.
References
Wexler R.R, Greenlee W.J, Irvin J.D,
Goldberg M.R, Prendergast K, Smith R.D,
Timmermans P.B. Nonpeptide angiotensin
II receptor antagonists: the next generation
in antihypertensive therapy. J Med
Chem1996; 39: 625–656.
Brunner H.R, Nussberger J, Waeber B.
The present molecules of converting
enzyme inhibitors. J Cardiovasc
Pharmacol. 1985; 7 Suppl 1:S2–S11.
Goodfriend T.L, Elliott M.E, Catt K.J.
Angiotensin receptors and their
antagonists. N Engl J Med. 1996; 334:
–1654.
Tuccinardi T, Calderone V, Rapposelli S,
Martinelli A. Proposal of a new binding
orientation for non-peptide AT1
antagonists. J Med Chem 2006; 49:4305–
Kubo K, Kohar Y, Yoshimura Y, Shibouta
Y, Furukawa Y . Nonpeptide angiotensin
II receptor antagonists. Synthesis and
biological activity of potential prodrugs of
benzimidazole-7-carboxylic acids. J Med
Chem 1993; 36:2343–2349.
Smith R.D, Chiu A.T, Wong P.C, Herblin
W.F, Timmermans P.B.M.W.M.
Pharmaco doi:10.1021/jm00068a011logy
of Nonpeptide Angiotensin-II Receptor
Antagonists. Ann Rev Pharmacol
Toxicol.1992; 32: 135–165.
Timmermans P.B, Chiu A.T, Herblin W.F,
Wong P.C, Smith R.D. Angiotensin II
receptor subtypes. Am J Hypertens1992;
: 406–410.
Bernhart C.A, Perreaut P.M, Ferrari B.P,
Muneaux Y.A, Assens J.L, Clement J,
Haudricourt F, Muneaux C.F,Taillades
J.E, Vignal M.A . A new series of
imidazolones: highly specific and potent
nonpeptide AT1 angiotensin II receptor
antagonists. J Med Chem 1993; 36:3371–
Buhl M.P, Furet P, Criscione L, de G. M,
Schimidilin T.S, LAttman R, W. J
.Valsartan: a potent orally active
angiotensin ii antagonist developed from a
structurally new amino acid series. Bioorg
Med Chem Lett 1994; 4:29–34.
Ellingboe J.W, Antane M, Nguyen T.T,
Collini M.D, Antane S, Bender R,
Hartupee D, White V, McCallum J, Park
C.H. Pyrido[2,3-d]pyrimidine angiotensin
II antagonists. J Med Chem 1994;37:542–
Judd D.B, Dowle M.D, Middlemiss D,
Scopes D.I, Ross B.C, Jack T.I, Pass M,
Tranquillini E, Hobson J.E, Panchal T.A.
Bromobenzofuran-based nonpeptide
antagonists of angiotensin II: A potent
antihypertensive agent with high oral
bioavailability. J Med Chem1994;
:3108–3120.
Keenan R.M, Weinstock J, Finkelstein
J.A, Franz R.G, Gaitanopoulos D.E,
Girard G.R, Hill D.T, Morgan T.M,
Samanen J.M, Peishoff C.E. Potent
nonpeptide angiotensin II receptor
antagonists. 2. 1- (Carboxybenzyl)
imidazole-5-acrylic acids. J Med Chem
;36:1880–1892.
Middlemiss D, Drew G.M, Ross B.C,
Robertson M.J, Scopes D.I.C, Dowle M.D,
Akers J, Cardwell K, Clark K.L, Coote S,
Idred C.D, Hamblett J, Hilditch A, Hirst
G.C, Jack T, Motana J, Panchal T.A, Paton
J.M.S, Shah P, Stuart G, Travers A. (1991)
Benzobromofurans: a new class of potent
non peptide antagonists of angiotensin II.
Bioorg Med Chem Lett 1991; 1:711–716.
Carini D. J, Duncia J. V, AldrichP. E,
Chiu A. T, Johnson A.L, Pierce M. E,
Price W. A, Santella J. B, Wells G. J,
WexlerR. R, Wong P. C, Yoo S.E,
Timmermans P. B. M. W. M.Nonpeptide
Angiotensin II Receptor Antagonists: The
Discovery of a Series of N-
(Biphenylylmethyl)imidazoles as Potent,
Orally Active Antihypertensive. J Med
Chem 1991; 34, 2525-2547.
Bali A, Bansal Y, Sugumaran M, Saggu
J.S, Balakumar P, Kaur G, Bansal G,
Sharma A, Singh M. Design, synthesis and
evaluation of novelly substituted
benzimidazole compounds as angiotensin
II receptor antagonists. Bioorg Med Chem
Lett 2005;15,3962-3965.
Dhvanit I. S, Sharma M, Bansal Y,Bansal
G, M. Singh. Angiotensin II AT1 receptor
antagonists: Design, synthesis and
evaluation of substituted carboxamido
benzimidazole derivatives European
Journal of Medicinal Chemistry 2008;43,
-1812.
Jat R.K,Jat J.L, Pathak D.P.Synthesis of
Benzimidazole Derivatives: As Antihypertensive Agents.E Journal of
Chemistry 2006;3:(13), 278-285.
Preston, Heterocyclic Compounds:
Benzimidazoles and Congeneric Tricyclic
compounds, Part-I, Vol-40, p-7.
Solomon Marmor, Laboratory methods in
Organic Chemistry, 1986, Surjeet
publications,p-284-285.
Badyal D.K, Lata H, Dadhich A.P, Animal
models of hypertension and effect of
drugs. Indian J of Pharmacology 2003;
(66), 349-362.
Bunag R.D, McCubbin J.W, Page I.H.
Lack of correlation between direct and
indirect measurements of arterial pressure
in unanaesthetized rats. Cardiovasc Res
;5(1): 24-31.
Gupta S.K.Drug Screening methods,
Jaypee Brothers Medical Publisher, New
Delhi,2004; pp 236-246.
Shreenivas M.T, Chetan B.P, Bhat A.R,
Synthesis and Pharmacological Evaluation
of Certain Schiff Bases and Thiazoldine
Derivatives as AT1 Angiotension-II (AII)
Receptor Antagonists. Journal of
Pharmaceutical Science and Technology
; 1 (2), 88-94.
A.A.Siddiqui, M.S.Wani. Indian. j.
chemistry. 43B, 1574, 1579(2004).
R.D.Bunag.J.W.McCubbin, I.H.Page.
Lack of correlation between direct and
indirect measurements of arterial pressure
in unanaesthetized rats. Cardiovascular
Res. 5(1): 24-31 (1971).
